Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal TumorsArun S Singh, J Randolph Hecht, Lee Rosen, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.
Cancer Discovery|May 17, 2012
Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitorsHubing Shi, Gatien Moriceau, Xiangju Kong, et al.
The Lancet. Oncology|July 20, 2014
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b studyAntoni Ribas, Rene Gonzalez, Anna Pavlick, et al.
Journal of Drug Targeting|July 20, 2018
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse modelsKei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Oncotarget|November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse modelKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Cancer Immunology Research|January 21, 2016
PD-1 Blockade Expands Intratumoral Memory T CellsAntoni Ribas, Daniel Sanghoon Shin, Jesse Zaretsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2023
Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 TrialDavid S Hong, Michael Postow, Bartosz Chmielowski, et al.
Cancer Discovery|July 30, 2021
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic MelanomaAntoni Ribas, Theresa Medina, John M Kirkwood, et al.
Oncotarget|February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse modelsKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Pageof 20